{"id":"W2796628418","doi":"10.1016/j.amjmed.2018.03.024","title":"Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program","year":2018,"lang":"en","type":"article","venue":"The American Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Cilag; Bristol-Myers Squibb; Bayer Vital; St. Jude Medical; AstraZeneca; Allergan; National Institutes of Health; H. Lundbeck A/S; Servier; Astellas Pharma; Daiichi-Sankyo; Bundesministerium für Bildung und Forschung; European Society of Cardiology; Boehringer Ingelheim; Deutsche Gesellschaft für Neurologie; European Commission; Sanofi; Bayer HealthCare; Pfizer; Actelion Pharmaceuticals; Novartis; Deutsche Forschungsgemeinschaft; GlaxoSmithKline; Eli Lilly and Company","keywords":"Medicine; Atrial fibrillation; Antithrombotic; Internal medicine; Cardiology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001003342,0.0001855905,0.0003983165,0.0009191635,0.0003280747,0.0006454385,0.0005169013,0.0004444155,0.00170037],"category_scores_gemma":[0.004169605,0.0002045059,0.0006076779,0.001489986,0.0001726487,0.0007675973,0.0008219034,0.00045971,0.0004494356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004387291,"about_ca_system_score_gemma":0.0008935754,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01411222,"about_ca_topic_score_gemma":0.03328085,"domain_scores_codex":[0.9992724,0.0001588506,0.0000928477,0.000171454,0.0001295703,0.00017489],"domain_scores_gemma":[0.9981654,0.000249624,0.0008991262,0.0001939962,0.0002296858,0.0002622562],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002033353,0.00004488714,0.995861,0.000009592799,0.0000963179,0.00005482348,0.00007487181,0.00003960566,0.00007207771,0.00006812833,0.001353788,0.002121564],"study_design_scores_gemma":[0.00002668179,0.00003607351,0.9989717,0.000009653997,0.0000438803,0.00007666403,0.0001298438,0.0001031015,0.00003167707,0.00003801393,0.0005282363,0.00000444306],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9859832,0.0003339943,0.0001510727,0.000460264,0.00003216153,0.00003573958,0.01024744,0.00002138729,0.002734713],"genre_scores_gemma":[0.9921294,0.0002533694,0.0001459433,0.0002525012,0.00003086241,0.00005054086,0.006302326,0.00001685834,0.0008181867],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01411222,"threshold_uncertainty_score":0.0280602,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1141239327855681,"score_gpt":0.3885523877357007,"score_spread":0.2744284549501326,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}